Translational Gastroenterology Unit (TGU)
About the TGU
The Translational Gastroenterology Unit hosts teams of scientists and clinicians working together to tackle major diseases affecting the gut and the liver. This includes cancers, infections and inflammatory diseases. A longstanding interest of the unit is inflammatory bowel disease (ulcerative colitis and Crohn’s disease), dating back to the era of Sidney Truelove, who developed the first trials and treatments. Together we are now pursuing studies of vaccines, diagnostics, biomarkers, genetics and new clinical interventions in a range of diseases including celiac disease, intestinal failure and auto-immune liver diseases. The unit hosts the Sidney Truelove chair and the Lee Placito chair and around 15 PIs across the different university sites who study various aspects of GI disease at the interface of clinical medicine and basic science. It also hosts a core Flow Cytometry Facility that offers a high-quality Flow Cytometry service to a variety of users. The TGU and flow cytometry facility are supported by the Biomedical Research Centre and Human Immune Discovery Initiative.
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
Wang K. et al, (2023), The British journal of general practice : the journal of the Royal College of General Practitioners, 73, 565 - 568
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.
Thomas TM. et al, (2023), Human vaccines & immunotherapeutics, 19
Thursday, 14 December 2023, 4.30pm to 6pm
Thursday, 25 January 2024, 4.30pm to 5.30pm
Thursday, 07 March 2024, 4.30pm to 5.30pm